Literature DB >> 23148033

A luminescent cyclometalated iridium(III) complex accumulates in mitochondria and induces mitochondrial shortening by conjugation to specific protein targets.

Baojiang Wang1, Yimin Liang, Hongjuan Dong, Tianfeng Tan, Bao Zhan, Jinping Cheng, Kenneth Kam-Wing Lo, Yun Wah Lam, Shuk Han Cheng.   

Abstract

We report the cellular properties of a luminescent cyclometalated iridium(III) complex, [Ir(pq)(2)(phen-ITC)](PF(6)) (Ir-ITC; Hpq=2-phenylquinoline, phen-ITC=5-isothiocyanate-1,10-phenanthroline), that efficiently and specifically labels mitochondria in living mammalian cells. Ir-ITC can be covalently conjugated to its protein targets, and its luminescence survived cell lysis, protein extraction, and gel electrophoresis under denaturing conditions. The conjugation of Ir-ITC with live-cell proteins is rapid and highly selective; the process requires active cellular metabolism, as the conjugation is abolished at nonphysiological temperature or in the presence of sodium azide. Based on measurements of the luminescence intensity, we have devised a biochemical fractionation procedure that allows the enrichment of the conjugated proteins, and their subsequent separation by two-dimensional gel electrophoresis (2DGE). Luminescent protein spots were picked from the gel and analyzed by mass spectrometry; this resulted in the identification of 46 proteins. Many of the strongly luminescently labeled proteins are mitochondrial proteins. One of the targets is VDAC1 (voltage-dependent anion channel 1). Consistent with known phenotypes of VDAC1 deregulation, prolonged exposure of cells to Ir-ITC led to significant mitochondrial shortening and fragmentation. As far as we know, this is the first report on the molecular characterization of the interactions of a luminescent dye with its biological targets. As many biological dyes exhibit specific intracellular staining patterns, the identification of their molecular targets can help elucidate the mechanisms behind their staining specificities and cytotoxicity. We believe our biochemical approach can be applied to identify the targets of a wide range of fluorescent and luminescent probes.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148033     DOI: 10.1002/cbic.201200517

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  5 in total

1.  Luminogenic iridium azide complexes.

Authors:  Jun Ohata; Farrukh Vohidov; Amirhossein Aliyan; Kewei Huang; Angel A Martí; Zachary T Ball
Journal:  Chem Commun (Camb)       Date:  2015-10-21       Impact factor: 6.222

2.  Mitochondrial imaging in live or fixed tissues using a luminescent iridium complex.

Authors:  Alexandra Sorvina; Christie A Bader; Jack R T Darby; Mitchell C Lock; Jia Yin Soo; Ian R D Johnson; Chiara Caporale; Nicolas H Voelcker; Stefano Stagni; Massimiliano Massi; Janna L Morrison; Sally E Plush; Douglas A Brooks
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

3.  Phosphorescent Ir(III) complexes conjugated with oligoarginine peptides serve as optical probes for in vivo microvascular imaging.

Authors:  Mami Yasukagawa; Aya Shimada; Shuichi Shiozaki; Seiji Tobita; Toshitada Yoshihara
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

4.  Re and (99m)Tc complexes of BodP3--multi-modality imaging probes.

Authors:  Laura H Davies; Benjamin B Kasten; Paul D Benny; Rory L Arrowsmith; Haobo Ge; Sofia I Pascu; Stan W Botchway; William Clegg; Ross W Harrington; Lee J Higham
Journal:  Chem Commun (Camb)       Date:  2014-09-24       Impact factor: 6.222

5.  Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents.

Authors:  Andrés Luengo; Isabel Marzo; Matthew Reback; Isabelle M Daubit; Vanesa Fernández-Moreira; Nils Metzler-Nolte; M Concepción Gimeno
Journal:  Chemistry       Date:  2020-09-02       Impact factor: 5.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.